Literature DB >> 15339579

[Clinical study on treatment of alcoholic liver disease by Qinggan Huoxue Recipe].

Guang Ji1.   

Abstract

OBJECTIVE: To study the effect of Qinggan Huoxue Recipe on alcoholic liver disease(ALD). Methods Effects were observed of Qinggan Huoxue Recipe on the symptoms, physical signs, liver function, blood lipid, markers of liver fibrosis, cytokine and ultrasonogram of ALD patients; the control groups were treated with Xiao Chaihu Decoction or general supportive treatment.
RESULTS: The effects of Qinggan Huoxue Recipe were better than that of the other treatments on anorexia, nausea, vomiting, jaundice, ALT, AST and TG; the effects of Qinggan Huoxue Recipe on GGT and VLDL were better than that of the general supportive treatment. Qinggan Huoxue Recipe could decrease the level of cytokines and markers of liver fibrosis, its total effective rate was better than that of Xiao Chaihu Decoction and general supportive treatment.
CONCLUSION: Qinggan Huoxue Recipe could prevent and cure ALD markedly, its mechanism might be: resisting lipid peroxidation, stabilizing the membrane of the hepatocytes, rectifying the disturbance of liver lipid metabolism, adjusting the immune function, anti-fibrosis, and promoting the metabolism of ethanol in the liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15339579     DOI: 10.3736/jcim20030206

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  2 in total

1.  The effects of high-dose qinggan huoxue recipe on acute liver failure induced by d-galactosamine in rats.

Authors:  Hong Zhu; Yang Zhang; Xiaoyu Hu; Cheng Yi; Sen Zhong; Yanyan Wang; Fang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-11       Impact factor: 2.629

2.  The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy.

Authors:  Chin-Chuan Tsai; Jia-Ping Wu; Yueh-Min Lin; Yu-Lan Yeh; Tsung-Jung Ho; Chia-Hua Kuo; Bor-Show Tzang; Fuu-Jen Tsai; Chang-Hai Tsai; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.